CORAR Leadership
CORAR Executive DirectorMichael J. Guastella, MS, MBA - Executive Director
Before joining CORAR in 2011, Michael held various sales and marketing leadership roles in the imaging, biotechnology, clinical laboratory, and radiopharmaceutical industries and was most recently the Vice President of Marketing and Product Development for Cardinal Health Nuclear Pharmacy Services. Michael has served on the CORAR Board of Directors for 10 years and has held other industry leadership positions including Co-Chairman of the CORAR Healthcare Policy Committee – Reimbursement. Michael received his B.S. and M.S. degrees from UCLA and earned his MBA from the UCLA Anderson School of Management.
2017 CORAR Corporate Officers
Chairman
Roy W. Brown - Vice President, Government Affairs & Strategic Alliances
Curium
Vice Chairman
David Pellicciarini - Vice President, Quality and Regulatory
Cardinal Health Nuclear Pharmacy Services
Secretary/Treasurer
Ira Goldman - Project Director, Strategic Supply
Lantheus Medical Imaging
2017 CORAR Board Members
- Bayer HealthCare Pharmaceuticals Inc.
Shaemus Gleason
- Cardinal Health Nuclear Pharmaceutical Services
Tiffany Olson, President, Nuclear Pharmacy Services
- Curium
Roy W. Brown, Vice President, Government Affairs& Strategic Alliances
- Eckert & Ziegler Radiopharma, Inc.
Hugh W. Evans, Director, Company Secretary
- International Isotopes Inc.
Steve T. Laflin, President & CEO
- Jubilant DraxImage Inc.
Norman LaFrance, MD, ME, FACP, FACNP; Chief Medical Officer, Vice President, Medical and Regulatory Affairs
- Lantheus Medical Imaging
Michael Duffy, Vice President, General Counsel
- Nordion Inc.
Phil Larabie, General Manager, Medical Isotopes
- NorthStar Medical Technologies, LLC
James T. Harvey PhD, Chief Science Officer
- Northwest Medical Isotopes
Carolyn Haass, Chief Operating Officer
- Pharmalucence Inc.
John Felock, Director of Sales, Marketing and Customer Service
- Progenics Pharmaceuticals, Inc.
Gary Lunger, Senior Director, Sales and Marketing
- Spectrum Pharmaceuticals, Inc.
Gene Menendez, Director, Strategic Payer Development, Associate Director, Lymphoma Accounts
- SHINE Medical Technologies
Katrina Pitas, Vice President, Business Development
Latest News
-
MITA and CORAR Support House Bill to Foster Access to Innovative Medical Imaging https://t.co/Riwxdv6noS #CORAR
-
CORAR Comments on FDA Draft 503B RP Compounding Guidance https://t.co/EJMpjHYcz4 #CORAR
-
CORAR Comments on FDA Draft Nuclear Pharmacy Compounding Guidance https://t.co/Hhcem9KabR #CORAR